A Case-Based Approach to Optimizing the Treatment of Antimicrobial-Resistant Gram-Negative Infections (CE Session)
Includes a Live Web Event on 04/30/2025 at 1:20 PM (PDT)
Description:
This session presents a case-based exploration of optimizing the treatment of antimicrobial-resistant Gram-negative infections, specifically Stenotrophomonas maltophilia, Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii. Through real-world examples, attendees will gain a deeper understanding of the latest evidence and guidelines for managing these complex infections. Key focus areas include strategies for addressing challenging resistance patterns in Pseudomonas aeruginosa and applying evidence-based treatments to improve patient outcomes. The session will also examine clinical approaches to effectively manage Stenotrophomonas maltophilia and carbapenem-resistant Acinetobacter baumannii infections.
This session is part of the Sepsis Alliance AMR Conference 2025.
Learning Objectives:
At the end of the session, the learner should be able to:
- Analyze strategies for optimizing the treatment of Stenotrophomonas maltophilia infections based on current evidence and guidelines;
- Evaluate approaches for optimizing the treatment of Pseudomonas aeruginosa infections, focusing on managing difficult-to-treat resistance;
- Apply evidence-based strategies for optimizing the treatment of carbapenem-resistant Acinetobacter baumannii infections in clinical settings.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Pranita Tamma, MD, MPH
Associate Professor of Pediatrics; Associate Professor, Department of Epidemiology
The Johns Hopkins University School of Medicine; The Johns Hopkins Bloomberg School of Public Health
Pranita Tamma, MD, MPH, is an Associate Professor of Pediatrics at The Johns Hopkins University School of Medicine. She is also an Associate Professor in the Department of Epidemiology at The Johns Hopkins Bloomberg School of Public Health. Her research focuses on elucidating the mechanisms of resistance in gram-negative organisms, developing and enhancing laboratory methods to identify gram-negative resistant organisms to enable critically-ill patients to be placed on appropriate antibiotic therapy as early as possible, and identifying optimal treatment strategies for patients infected with multidrug-resistant gram-negative infections. She is the lead author of the Infectious Diseases Society of America Antimicrobial Resistance Treatment Guidance.